Overview

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers

Status:
Not yet recruiting
Trial end date:
2020-06-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and Safety/Tolerability of CKD-386
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical